Why National Veterinary Care Ltd share price is up 6% today

The National Veterinary Care Ltd (ASX:NVL) share price is having a strong finish to the week. Here's why…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The National Veterinary Care Ltd (ASX: NVL) share price has been a big mover in morning trade.

At the time of writing the growing veterinary company's shares are up 6% to $2.50.

What happened?

This morning National Veterinary Care provided an update on its acquisition pipeline.

As well as noting that it has successfully completed the acquisition of one veterinary clinic in New South Wales, the company advised that it has entered into binding agreements to acquire four clinics and has entered into heads of agreement for a further two veterinary clinics located in Queensland.

Subject to completion of due diligence, finalisation of acquisition agreements, and satisfaction of conditions precedent, management expects these acquisitions to settle by 30 September 2017.

According to the release, these seven clinics are expected to deliver annual revenue of approximately $10.3 million, with aggregate annual earnings before interest and tax (EBIT) of approximately $2.4 million.

The total consideration for the seven acquisitions expected to be $11.7 million, with a total upfront payment of $9.8 million and a deferred component of $1.9 million.

Should you invest?

At less than 5x estimated EBIT, I believe this deal is great value for money and I can't say I'm surprised to see its shares charge higher today.

In my opinion National Veterinary Care is one of the best small-cap shares to invest in on the Australian share market right now and a great alternative to industry giant Greencross Limited (ASX: GXL).

After all, with the veterinary care market highly fragmented, I believe the company has the potential to grow significantly through acquisitions like the ones announced today.

For this reason I would class the company as a buy.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Greencross Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »